|
Medrol (Methylprednisolone)
|
|
Endocrine/Metabolic
|
|
Adrenocortical steroid
|
|
Multiple Sclerosis, methylprednisolone, methylprednisolone acetate, methylprednisolone Sodium succinate, shock, severe lupus nephritis. This is a corticosteroid used to treat swelling. It is used for many conditions, among them: allergic reactions, skin diseases, breathing problems, certain cancers, blood disorder, eye problems, arthritis, digestive problems and hormone replacement.
|
|
(Adults and children) Initial dosage 4 to 48mg/day depending on disease.
|
|
Category C.
|
|
Fluid retention, Potassium loss, High Blood Pressure, muscle weakness, Seizures, arrhythmias, fatal arrest or circulatory collapse, Cataracts, pancreatitis, hypokalemia, muscle weakness, hypokalemia, acne.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
|
|
|